DRUG USE--GENERATIONAL TRANSMISSION IN MINORITY YOUTH
吸毒——少数民族青少年的代际传播
基本信息
- 批准号:6356111
- 负责人:
- 金额:$ 53.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-04-15 至 2004-03-31
- 项目状态:已结题
- 来源:
- 关键词:adolescence (12-20) adult human (21+) behavior behavioral /social science research tag clinical research culture disease /disorder proneness /risk drug abuse epidemiology family structure /dynamics generation difference human subject longitudinal human study parent offspring interaction peer group personality substance abuse related behavior
项目摘要
The purpose of this project is to study the transmission across three
generations of the childhood precursors of drug use/drug abuse. This
longitudinal study began in 1990 (T1) when first generation (G1) mothers
and second generation (G2) adolescents were assessed. Data were
obtained on cultural and family context, parent child-rearing, and
personality/behavioral variables. Five years later (T2), the G2
adolescents were reassessed. At the T2 data collection, the original
T1 measures were repeated, and additional data were gathered from both
mother and child on cultural influences, personality/behavior, parent-
child relations, peer drug use and self drug use. The T1-T2 data
established that adolescent factors do influence later drug use; we now
propose to further investigate these influences by studying the G3
offspring of the G2 original study adolescents. The G3 child will be
evaluated at age 7-12 in terms of childhood precursors of later drug
use/drug abuse. We will then trace the intra- and intergenerational
pathways (T1-T3) to determine how drug-prone characteristics are
transmitted. The hypothesized pathway, based on our Family
Interactional Model, is that cultural factors and parent personality
risk characteristics (e.g. unconventionality, poor control of emotions)
lead to parent-child mutual detachment (e.g., less warmth, more
conflict). This then leads to the development in the child of risks for
drug use/drug abuse. We hypothesize that this pathway, already shown
in the G1 parent and G2 child, will be repeated for the G2 child (now
a parent) and his/her offspring. Also of interest is our examination
of risk (drug-conducive) and protective (nondrug-conducive) intra- and
intergenerational interactions as they affect G3 child outcome. The
sample size for the study is 325 7-12-year-olds and their parents. T3
data will be collected using self-report. The analytic techniques will
include structural equation and hierarchical regression. The
significance of the study lies in its delineation of generational
factors implicated in the development of childhood precursors of drug
use/drug abuse. (By focusing on ways to improve the psychosocial
environment of the young child at risk, one can not only lesser the
likelihood of later drug use, but also effect changes that "break the
chain" of generational risk transmission.)
该项目的目的是研究三个传输
几代儿童吸毒/滥用药物的前兆。 这
纵向研究始于1990年(T1),当时第一代(G1)母亲
和第二代(G2)青少年进行了评估。 数据
文化和家庭背景,父母养育子女,
个性/行为变量。 五年后(T2),G2
青少年被重新评估。 在T2数据收集时,原始
重复T1测量,并从两个样本中收集额外数据。
母亲和孩子的文化影响,个性/行为,父母-
儿童关系,同伴吸毒和自我吸毒。 T1-T2数据
确定青少年因素确实会影响以后的药物使用;我们现在
我建议通过研究G3来进一步研究这些影响
G2原始研究青少年的后代。G3儿童将在
在7-12岁时评估儿童后期药物前体
使用/滥用药物。 然后我们将追踪
途径(T1-T3),以确定药物倾向的特点是如何
传来 假设的路径,基于我们的家庭
干预模式,即文化因素和父母个性
风险特征(例如,非常规性、情绪控制不良)
导致父子相互分离(例如,少一点温暖,多一点
冲突)。 这就导致了儿童的发展风险,
药物使用/药物滥用。 我们假设这条通路,
在G1父代和G2子代中,将对G2子代重复(现在
父母)和他/她的后代。 同样有趣的是我们的考试
风险(药物有益)和保护(非药物有益)
两代人之间的互动影响G3儿童的结局。 的
研究的样本量为325名7-12岁的儿童及其父母。 T3
将使用自我报告收集数据。 分析技术将
包括结构方程和分层回归。的
研究的意义在于它描绘了代际
与儿童期毒品前体形成有关的因素
使用/滥用药物。 (By专注于如何改善心理社会
在危险的幼儿环境中,人们不仅可以减少
可能以后使用毒品,但也影响变化,“打破了
(三)“代际风险传递链”。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GARY ROSENBERG其他文献
GARY ROSENBERG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GARY ROSENBERG', 18)}}的其他基金
MATRIX METALLAPROTENINASES AS BIOCHEMICAL MARKERS IN VASCULAR DEMENTIA
基质金属蛋白酶作为血管性痴呆的生化标志物
- 批准号:
8166591 - 财政年份:2009
- 资助金额:
$ 53.78万 - 项目类别:
MATRIX METALLAPROTENINASES AS BIOCHEMICAL MARKERS IN VASCULAR DEMENTIA
基质金属蛋白酶作为血管性痴呆的生化标志物
- 批准号:
7952041 - 财政年份:2008
- 资助金额:
$ 53.78万 - 项目类别:
MATRIX METALLAPROTENINASES AS BIOCHEMICAL MARKERS IN VASCULAR DEMENTIA
基质金属蛋白酶作为血管性痴呆的生化标志物
- 批准号:
7716579 - 财政年份:2008
- 资助金额:
$ 53.78万 - 项目类别:
CORRELATION OF MATRIX METALLOPROTEINASE AND FUNCTIONAL OUTCOME FOLLOWING TRAUMA
基质金属蛋白酶与创伤后功能结果的相关性
- 批准号:
7952063 - 财政年份:2008
- 资助金额:
$ 53.78万 - 项目类别:
CORRELATION OF MATRIX METALLOPROTEINASE AND FUNCTIONAL OUTCOME FOLLOWING TRAUMA
基质金属蛋白酶与创伤后功能结果的相关性
- 批准号:
7716620 - 财政年份:2008
- 资助金额:
$ 53.78万 - 项目类别:
MATRIX METALLAPROTENINASES AS BIOCHEMICAL MARKERS IN VASCULAR DEMENTIA
基质金属蛋白酶作为血管性痴呆的生化标志物
- 批准号:
7606887 - 财政年份:2006
- 资助金额:
$ 53.78万 - 项目类别:
MAGNETIC RESONANCE IMAGING AND SPECTROSCOPY IN VASCULAR DEMENTIA
血管性痴呆的磁共振成像和波谱检查
- 批准号:
7205275 - 财政年份:2004
- 资助金额:
$ 53.78万 - 项目类别:
A Serological Marker for Hepatocellular Carcinoma
肝细胞癌的血清学标志物
- 批准号:
6689941 - 财政年份:2003
- 资助金额:
$ 53.78万 - 项目类别:
DRUG USE--GENERATIONAL TRANSMISSION IN MINORITY YOUTH
吸毒——少数民族青少年的代际传播
- 批准号:
6515668 - 财政年份:1999
- 资助金额:
$ 53.78万 - 项目类别: